Evidence map›Paper›PMID 33242938›Full record

ArticleAnaesthesiology intensive therapy2021

A response to comment on prognostic factors in burns.

Michał Zieliński, Piotr Wróblewski, Jerzy Kozielski

Abstract readLetterComment
In one paragraph

Article in Anaesthesiology intensive therapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Michał ZielińskiDepartment of Lung Diseases and Tuberculosis, Medical University of Silesia in Katowice, Poland.
Piotr WróblewskiBurn Treatment Centre in Siemianowice Śląskie, Poland.
Jerzy Kozielski

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We would like to thank Dr Ewington et al. for the commentary on our review about prognostic factors in burns. First we would like to comment on the role of frailty in assessment of burns. The elderly population is of special interest in all fields of clinical medicine, owing to the ageing of the world population [1]. The definition of frailty is relatively concise. It is defined as a state of depletion of the homeostatic reserve due to changes accumulated during lifetime. In consequence, resolution of stressor sequelae is impaired [2]. Although the definition is straightforward, the methods of its application and quantification of frailty are not unequivocally accepted [3]. Ward and Romanowski in their papers used the Clinical Frailty Scale [4]. Other developed scales, to mention only a few, are the general Korean Frailty Index for Primary Care [5], the Modified Frailty Index 5 (mFI-5) [6], the more specialized Emergency General Surgery Frailty Index [7], and the Burn Frailty Index [8]. Some of them were evaluated in surgery patients, and the Burn Frailty Index was developed by Maxwell specifically to be used in burn patients [8]. A study comparing the usefulness of various frailty scales in a burn ward would be a welcome addition to the discussion about burn outcomes. We would also like to address one more aspect of frailty. Generally, the term is connected with the elderly population, i.e. more than 65 years old. This is based on the fact that one's frailty is a sum of deficits accumulated over the whole lifetime [9]. Yet even in younger age groups various tools used to assess frailty show a relatively high percentage of frail people [10, 11]. Research including patients undergoing orthopaedic surgery has proven that frailty assessment is a viable choice to predict complications even in younger groups [12]. Therefore we assume that frailty indexes will gradually become tools used also in younger groups of patients.

Indexed as

BurnsFrailtyAgedHumansPrognosis

Identifiers

PMID33242938
PMCPMC10158441

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.